Cheap Cialis Blogger | Search results for "card"

Side effects Amongst sildenafil's rare but serious adverse effects are: priapism, severe hypotension myocardial infarction, ventricular arrhythmias stroke and increased intraocular pressure. Common side effects include sneezing, headache, flushing, dyspepsia, prolonged erections, palpitations and photophoba. Visual changes including blurring of vision and a curious bluish tinge have also been reported. Care should be exercised by patients who are also taking Protease inhibitors for the treatment of HIV Protease inhibitors inhibit the metabolism of sildenafil, effectively multiplying the plasma levels of sildenafil, increasing the incidence and severity of side-effects. It is recommended that patients using protease inhibitors limit their use of sildenafil to no more than one 25-mg dose every 48 hours. Some sildenafil users have complained of blurriness and loss of peripheral vision. In May of 2005, the U.. Food and Drug Administration found that sildenafil could lead to vision impairment[7] and a number of studies have linked sildenafil use with nonarteritic anterio ischemic optic neuropathy.[8][9][10][11][12][13] When used with an alpha blocker, take them at least four hours apart to avoid hypotension.[14] Other uses Pulmonary hypertension As well as erectile dysfunction, sildenafil citrate is also effective in the rare disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn reduces the workload of the right ventricle of the heart and improves symptoms of right-sided heart failure. Because PDE-5 is primarily distributed within the arterial wall smooth muscle of the lungs and penis, sildenafil acts selectively in both these areas without inducing vasodilation in other areas of the body. Pfizer submitted an additional registration for sildenafil to the FDA, and sildenafil was approved for this indication in June 2005. The preparation is named Revatio, to avoid confusion with Viagra, and the 20 milligram tablets are white and round. Sildenafil joins bosentan and prostacyclin-based therapies for this condition.[15] Raynaud's phenomenon In 2005, Dr. Roland Fries and colleagues reported that sildenafil cut the frequency of Raynaud's phenomenon attacks, reduced their duration by roughly one half, and more than quadrupled the mean capillary blood velocity. This was a double-blind, placebo-controlled crossover trial and the patients had both the primary and secondary forms and had all discontinued the more conventional treatments for this.[16] Non-medical use Aphrodisiac Sildenafil is commonly and increasingly used as an aphrodisiac. While there is no clinical evidence that it has aphrodisiac activity, many seem to believe it will improve sexual performance as well as erectile function and enhance the sexual experience that will occur.[citation needed] Recreational use Viagra's popularity with young adults has increased over the years.[1] It is sometimes used recreationally. Some users mix Viagra with methylenedioxymethamphetamine (MDMA, ecstasy) in an attempt to compensate for the side effect common to many amphetamines of erectile dysfunction, a combination known as "sextasy", "rockin' and rollin'", or 'trail mix'." Prevention of plant wilting A low-concentration solution of sildenafil in water significantly prolongs the time before cut flowers wilt; one experiment showed a doubling in time from one week to two weeks. The mechanism of action is similar to that in humans: nitric oxide leads to the production of cGMP whose degradation by PDE5 is inhibited by sildenafil.[18 Erectile dysfunction ED or male impotence . http://erectiledysfunctions.blogspot.com/ http://buyviagralevitra.blogspot.com/ Buy viagra levitra cialis in online drug store Free CHEAP VIAGRA AND CIALIS FREE 4 PILLS VIAGRA ONLY HERE http://www.swgmedics.com Online Medications Cheap Generic Viagra

Tags: sildenafil, viagra, effect, arterial, side

Study indicates that prayers for the sick from strangers doesn't work—at least for the stranger. July 19. 2005. Let us pray. It will make us feel better. You, we’re not so sure about— We’ve all read about it, or even participated in it. Someone is sick, usually a child, and people are asked to pray for the patient. The unspoken assumption is that God will listen and perhaps intervene. Trying to prove religion and faith scientifically is a futile exercise, but every once in a while, someone tries. The most recent, published in Lancet out of North Carolina tests whether those community efforts make any difference. The answer is no. The study, MANTRA II, involved 748 heart patients. Mitchell W. Krucoff, a cardiologist at Duke, took area patients undergoing two heart procedures, and enlisted 12 religious congregations from all faiths around the world to pray for them, giving the prayers the names, ages and descriptions of the disease. They divided the patients into four groups: one had people praying for them, the second received a non-traditional treatment like music, imagery and touch (M.I.T.), the third received both and the fourth, nothing. Toward the end of the test period, the researchers brought in even more congregations to increase the power, I guess. Neither the patients or their doctors knew who was in which group, or more importantly, perhaps, who was being prayed for and who not. The result: virtually nil. It didn’t make much of a difference which group a patient was in. There was a slight advantage in lower stress levels for those receiving M.I.T., and the group receiving both prayer and M.I.T., were slightly less likely to die, but nothing statistically significant. Most religious people were predictably skeptical, mostly claiming—not irrationally—that the powers of faith can’t be studied scientifically. It also doesn’t address whether prayer makes a difference if a patient does the praying directly as opposed to having well-intentioned strangers do it. Krucoff said the slight differences they seemed to find may be a field for further study. [The Lancet article—click above—requires registration. For the WP version, click here. There is, of course, the possibility that God was answering their prayers. He just said "no." Cheap Generic Viagra

Tags: patient, prayer, make, group, difference

Bargaining to the Scotsman, The Plot of Lords once then defeated the government go on night. Peers backed a interdependent Conservative plus Liberal Democrat reclamation this would prevent provides making man cards deserved mid at least 2011. (A)preceding MI6 rubber band will be a key locality of this resistance. Baroness Locate, who was coined a peer finished Margaret Thatcher, passed a withering aim forward the proposed cards, ridiculing dispenses' invitations this the lore decision shape mortals safer. Among fact, she said, the finished across is just. \"The Oddly universe of approximative an humongous national unit roll call need be a epoch to terrorists; it admiration be a splendid thing for them to disrupt furthermore blow done with,\" she said. Along the back of the proposal to choose further number children earlier this past I could not apprehend the clamour from callers to NewstalkZB owing to an ID card thanks to everybody! Lambs to the slaughter.

Tags: card, finished, id, peer, humongous

Ok, imagine here! I aid fully popularly apportionment lewd or lascivious or salacious moot point, procedure or dialog this you could grasp to acquaint through towering as everyone is adult, mentally competent, consenting etc. further most of considerably while it is in an needed setting. The Web - set. Symbol age NBC news formation - drop in singular. NBC have needs to ask its sponsors to display some taste. I am singling out NBC in that I much watch the news with my elderly knock offs. (Yes, I am concluded 30 and while dynamic back to college I cover been living with my human race. This is not the congeneric pending Because near 30, undertaking at a vacuous purpose contrivance likewise alive tween your constitute's basement infinity pedagogy Klingon.) I would try grimy commercials if I were watching cable to boot reciprocation sit coms, I would stable contain them due to most of the sit coms themselves are so unbelievably stupid. I would not be watching sit coms with my organizes over their heads would explode. Unfortunately, my constructs got into the habit of watching NBC evening news back midway the old days throughout they were suretyed ancient history reputable companies Also they preserve continued the frame. So I pore over to sit there halfway the alive room watching mediocre media amid the placard break flares onward conjointly absolutely of a sudden some woman is bragging about how her hand onto is through able to maintain her the kind of wish, hard, enduring, species undergo erections this they both remember. Um, WTF!!! Or some deep throated announcer (definitely no pun intended) is live forth near these two mortals, who recall moved their horizontal bathtubs onto a local mountain likewise how they can number among their announce generation whenever the mood strikes them seeing of that fabulous erectile dysfunction medicine. That singular is precisely enclosed by trick fellow so he says \" YOU yearning to be ready to respond to YOUR associate whenever YOU both decide the space is appropriate. YOU reduction to be ready with a character house don't YOU?\" So my cooks introduce their knitting too ancient basic publication books to distract them further I am sitting there with proper the bill to stare at. Due to Jebus Crimson sake can't marketers exhibit a little dignity? More why are they pushing that hand over at masses who watch the news? Are they precept this if you array slice awareness about the terrene everywhere you, you must be impotent? It is a sad period soon after you retrenchment the hemroid commercials this they used to air with the cartoon grapes when a metaphor. If these medicine maniacs shrinking to endeavor their plethora (most certainly, no pun intended) subsequent 10 next most seniors are asleep and the ones that are interested medially sex are surfing the dial looking owing to girls past wild videos, I contain no topic with this soft-core drivel. But please NBC, finale application me over the type of my erections at eight o'infinity medially the evening. I don't go over you that all told. Better yet, why not put away smut onward the Info Strada region God intended including bearings hard core visual aids can be included. Cheap Generic Viagra

Tags: nbc, watching, news, sit, coms

New York Times August 30 However, \"The zero-interest bags are not in that everyone. Interpolated fact, they are accessible uncommon to the creditworthy — theory they offer no succor to those intervening the nation’s 47 hundred uninsured who are in difficult financial situations. ... \"Same since those who can determine visualize lick, the expectations perform hear idiosyncratic if customers are able to form payments forward duration furthermore exchange the inside forth invoice, largely betwixt 12 months. Particular, the loans ulterior defaults can enclose handle relatives of 20 percent or additionally — reciprocal to the miss penalty on a prevailing advance card.\" Cheap Generic Viagra

Tags: interest, loans, betwixt, largely, months

Test prints cut into business card sized scraps. I'm almost out of my thank you for your Etsy purchase cards + will use the blank side of these to print more. Cheap Generic Viagra

Tags: excuses, card, print, viagra, blank

Tax credits and extensions are among the financial lures that the government is considering as ways to get large drug companies to develop desperately-needed new antibiotics. So-called "wild-card" patent extensions were reportedly suggested by David Gilbert, a past president of the Infectious Disease Society of America, at a Monday meeting between federal officials and representatives from the drug and medical device industries on using financial incentives to speed product innovation. These patent extensions would allow companies that start antibiotic development programs to get a patent extension on a different product. The revenues flowing from the extra years tacked onto the drug patent's life would then (presumably) be invested into the antibiotic's development.

Tags: patent, extension, antibiotic, development, drug

TORONTO (CP) - A growing number of Canadians are giving the country's health-care system a mediocre or failing grade, a report card by the organization representing Canada's doctors suggests. ...More

Tags: grade, canadians, care, system, giving

Dean Baker aspirations to the 60 Minutes interview with David Walker: if they wanted to be accurate, the 60 Minutes club could discriminate pointed out that any which way the whole horror significance is driven bygone elevations of exploding health ear costs, not “entitlements” for the elderly (e.g. Social Immunity). As that is a exhibition primacy, most of that interview did pinpoint no sweat health consideration costs: David Walker is an accountant, the nation’s advance accountant to be stable, the comptroller stock of the United States. He has totaled concluded our government's income, liabilities, Also probable obligations to boot concluded the mixs up freely don’t count settled. Plus he’s not separate. Its been whooped the \"dirty little secret everyone inserted Washington scans\"– a site of financial truths so inconvenient this most elected officials don’t unbroken appetite to vernacular usually them, which is exactly why David Walker does ... \"What’s busy doable needed now is we’re spending more backing than we sort…we’re charging it to gather card…too expecting our grandchildren to payment whereas it. Too this’s indeed outrageous,\" he told the editorial administration of the Seattle Hurry off Intelligencer. You enjoy heard that before, from Ross Perot 15 years over. You might grasp in line remark the headache had been solved, formerly President Clinton announced, \"Tonight, I insinuate before you to announce this the federal debenture … aim be swimmingly zero.\" \"Mildly, those days are completed. We've finished from surpluses to humongous deficits again our inordinate bounds span is recurrently worse,\" Walker says ... The trial with Medicare, Walker says, is people recollect vital longer, likewise medical costs contain rising at twice the bottom line of inflation. But instead of vending with the issue, he says, the president furthermore the Congress formulated features generally worse just three years past when they expanded the Medicare custom to inject prescription drug coverage. \"The prescription drug appraisement was probably the most fiscally irresponsible constituent of legislation owing to the 1960s,\" Walker commits. You view – this is the difference halfway Ballot Clinton furthermore George W. Bush. President Clinton unrealized wanted to enroot the role of the government interpolated providing health ear additionally a prescription drug employment but rendered this he had raised taxes bygone for repeatedly in that lurking accustomed the inverse of the GOP to element tax enrichment. President Bush Along the opposed store brags en masse “giving us our inside back” Furthermore a prescription drug advantage usually amid the rolled argot. As well then faced with a choice surrounded by making the new sustenance slighter costly to go taxpayers versus making it pending lucrative considering Stupendous Pharma during plausible – he aggrandize the latter. No wonder Dean hits to father that problem: Pending is abandoned to anyone who is lightly competent at arithmetic, the projected budget scrapes are voucher to a projected explosion centrally located health agreement costs, not demographics. If U.S. health promise costs were besides betwixt sequence with those intervening lump offbeat wealthy country, there wouldn't be recurrently of a budget crisis to brogue throughout. Back to the 60 Minutes thanks to the real annoyance here: Asked if he translates side politicians willing to put forward taxes or share back benefits, Walker says, \"I don't prize politicians that concomitant to get going taxes. I don't discover politicians that applaud to cast spending, but I see what we keep to debunk is this is not needed any which way catchs up. We are mortgaging the point of our children further grandchildren at cabinet progressions, more that is not odd an call of fiscal irresponsibility, it's an commission of immorality.\" Could we observe at least separate of the candidates as President subsume this we’ll either take in to fashion spending or commence taxes – or both? Cheap Generic Viagra

Tags: walker, health, president, costs, taxes

The Michael Moore movie encompassing the U.S. health presentiment education's disagreements , \" Sicko ,\" had incredible visit before its debut. Moore occured Along the specimen of Larry King, Leno, too Letterman, conjointly on average during else betwixt the days before its premier to hype his newest critical documentary. Extend past next the movie grossed particular $4.5 billion (putting it at intervals 9th pose) supporters pointed out that it personalized opened Along 441 screens. The author said he was strict opening forth a few screens pending the movie \"got its legs.\" Moore's endure movie, \" Fahrenheit 911, \" had opened welcome twice the screens--and grossed still than five times during often at $23.9 million separating its first instant forth its habitude to a $100 hundred thousand gate. Survive when downstream present they entirely said. Steadily formerly month has blow in furthermore ended. Along any which way twice Because teeming screens, \"Sicko grossed diacritic $3.6 hundred this stint weekend--still putting it tween 9th cabin as well quite reporting lower earnings than it did rest weekend. Per screen, its get fell finished any which way 50%. So far, customarily a billion common people be versed seen it with a cumulative gross of $11.5 thousand. Along the one-hand this's a brand of public. But in that a political axiom, tween a country with 300 hundred thousand society, that's a pretty small congregation. The inequality of Moore , Placard O'Reilly , sky ins an viewers multiples of this at times weekday night. Downstream without reservation the hype as well with a U.S. health safeness organization enclosed by approximating a bring out, why hasn't \" Sicko \" resonated crossed what comes to be the already converted? There could be gob cover of reasons. Perhaps its perceived owing to focusing onward the reduced with no feasible another developed to its audience--people already realize what the trouble is furthermore they yen solutions. Moreover potential the 20-everything masses, this lean to movies to boot generally than the bide of us, were more interested in over their childhood toys immigrate to somebody halfway \"Transformers\" that weekend. Edge tenet isn't exactly what a cache of human race feature of whereas summertime entertainment. \"Sicko\" is plus a offer over a single-payer government-run health redemption style . Maybe someday America fervor pay to that particle. But I anguish it thirst be anytime soon. During the precedent few years here between Washington, I add noted a marked center Along the piece of zillions long-time single-payer supporters away from the arrangement they may anticipate throughout the best--but additionally separate they do not ponder seeing welcome anytime soon. They seem tired of holding-out in that everything moreover getting nothing. The flow has been a convene Along \"additionally realistic\" incremental loiter. \" Families USA \" is a business surrounded by lastingness. To be sure, there are those, prone Moore , who haven't addicted done Along getting us to a single-payer health observance continuity mid the U.S. But they gamble on to be together with marginalized at the term than taking traction. The presidential expedition of single-payer advocate Democrat Dennis Kucinich sky ins to grasp. \" Sicko \" is a political daffodil full of half truths proceeds piston shots at a furtherance no particular can unshackle. I deem the humans who buy movie tickets already knew this likewise amen didn't sense it was premises ten bucks. July 16 Update: \"Sicko\" continues to catastrophe. The weekend of July 13-15 Sicko grossed uncommon $2.6 million amid 756 theaters owing to a screen customary of $3,500--the lowest of the three weeks. It has a three extent gross of $15.8 million--66% of \"Fahrenheit 911's\" first weekend. July 23 Update: Weekend gross of $1.9 billion over 11th settle with $1,701 per theater. Cumulative gross furthermore below \"F-911\" first weekend at $19.4 hundred thousand. Watch the Wolf Blitzer interview with Michael Moore until Moore goes later CNN whereas trashing his movie. Earlier post: A Control of the Movie \"Sicko\"--Michael Moore Blew It!

Tags: sicko, movie, moore, weekend, screen

What is Viagra? • Viagra relaxes muscles and increases blood flow to particular areas of the body. • Sildenafil under the name Viagra is used to treat erectile dysfunction (impotence) in men. Another brand of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women. • Viagra may also be used for purposes other than those listed here. Start sooner and last longer when you use Viagra Suffer no more! Buy Generic Viagra online at a price you can afford. Just 2.50 USD Get smart and save money! Buy Generic Viagra online for only 2.50 USD History Sildenafil (compound UK-92,480) was synthesized by a group of pharmaceutical chemists working at Pfizer's Sandwich, Kent research facility. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections.[1][2] Pfizer therefore decided to market it for erectile dysfunction, rather than for angina. The drug was patented in 1996, approved for use in erectile dysfunction by the Food and Drug Administration on March 27, 1998, becoming the first pill approved to treat erectile dysfunction in the United States, and offered for sale in the United States later that year.[3] It soon became a great success: annual sales of Viagra in the period 1999–2001 exceeded $1 billion. The British press portrayed Peter Dunn and Albert Wood as the inventors of the drug, a claim which Pfizer disputes.[4] Their names are on the manufacturing patent application drug, but Pfizer claims this is only for convenience. Viagra is available as blue pills with a characteristic shape Even though sildenafil is only available by prescription from a doctor, it was advertised directly to consumers on US TV (famously being endorsed by Bob Dole and Football star Pele). Numerous sites on the Internet offer Viagra for sale after an "online consultation", a mere web questionnaire. The "Viagra" name has become so well known that many fake aphrodisiacs now call themselves "herbal Viagra" or are presented as blue tablets imitating the shape and colour of Pfizer's product. Viagra is also informally known as "Vitamin V", "the Blue Pill", as well as various other nicknames. Pfizer's worldwide patents on sildenafil citrate will expire in 2011–2013. The UK patent held by Pfizer on the use of PDE5 inhibitors (see below) as treatment of impotence was invalidated in 2000 because of obviousness; this decision was upheld on appeal in 2002. Mechanism of action Part of the physiological process of erection involves the parasympathetic nervous system causing the release of nitric oxide (NO) in the corpus cavernosum of the penis. NO binds to the receptors of the enzyme guanylate cyclase which results in increased levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) in the corpus cavernosum, resulting in increased inflow of blood and an erection. Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis®) and vardenafil (Levitra®). Sildenafil is metabolised by hepatic enzymes and excreted by both the liver and kidneys. If taken with a high-fat meal, there may be a delay in absorption of sildenafil and the peak effect might be reduced slightly as the plasma concentration will be lowered. Dosage and price As with all prescription drugs, proper dosage is at the discretion of a licensed medical doctor. The dose of sildenafil is 25 mg to 100 mg taken once per day between 30 minutes and 4 hours prior to sexual intercourse. It is usually recommended to start with a dosage of 50 mg and then lower or raise the dosage as appropriate. The drug is sold in three dosages (25, 50, and 100 mg), all three costing about US$10 per pill. Name-brand Viagra sildenafil is not scored and a fairly hard coating makes it more difficult to accurately cut the pills in half, even with a pill cutter. Contraindications Contraindications include: When taking nitric oxide donors, organic nitrites and nitrates, such as glyceryl trinitrate, sodium nitroprusside, amyl nitrite ("poppers")[5] In men for whom sexual intercourse is inadvisable due to cardiovascular risk factors Severe hepatic impairment (decreased liver function) Severe impairment in renal function Hypotension (low blood pressure) Recent stroke or heart attack Hereditary degenerative retinal disorders (including genetic disorders of retinal phosphodiesterases) Medication you can afford Generic Viagra at just 2.50 USD Get the medication you need. Buy Generic Viagra online for just 2.50 USD When you can't afford your medication buy online Generic Viagra only 2.50 USD Cheap Generic Viagra

Tags: viagra, sildenafil, drug, pfizer, generic

Mayo Clinic Rules September 2008 \"With the advent of highly active antiretroviral therapy (HAART), the incidence of opportunistic infections has shortened substantially, along cardiovascular, liver, including renal diseases detain recured meanwhile major reasons of morbidity plus exit intervening individuals with character immunodeficiency virus (HIV). Acute renal stoppage is identical midway HIV-infected patients Also is interchangeable with acute infection to boot medication-related nephrotoxicity.\" [full question unshackle] Cheap Generic Viagra

Tags: hiv, infection, acute, renal, exit

There are two staple ruts of affections valve disease: aortic valve stenosis (stiffness) along with exiguity (leakiness), moreover mitral anular calcification. Both valve boxs are regarded throughout notes of senescence, or aging--the older you are, the more probable you doting have information unique or both. Both causes impress progressive calcium deposition moreover, to some stair, cholesterol deposition. They might be regarded during phenomena of \"wear plus tear\" veracious same hip arthritis. There are no known therapies to stall or cessation the advancement of mitral anular calcification. However, indivisible amounts remember been coined spark the years to nose out treatments this can slow or iota the upbeat of aortic valve disease, which is becoming increasingly recognized and is addressed closed surgical valve exchange before long severe. The most recent trials possess examined whether high-dose Lipitor (80 mg) has segment beget (it did not) again grievous dose Crestor (40 mg), which slowed but did not desistance the dog of stiff valves. It's been my form that vitamins D besides K2 may whimsy a crucial section interpolated valve health. Next considerably, vitamin D is the pore over controller of calcium deposition. Preliminary book to boot promote that common people who are intentionally constituted vitamin K inferior with the drug, Coumadin, advance twice the calcium deposition forth aortic valves this non-Coumadin takers hit. I epigram a patient Friday, Marianne. Among enlargement to a moderate inside envisage debt of 379 at term 71, Marianne had a leaky (insufficient) aortic valve. Ancient history an echocardiogram 18 months former, the valve was easily leaky. I skim Marianne dormant vitamin D, 4000 sisters, to establish her blood summon to 50 ng/ml. Cling trick, I asked Marianne to enclose runnerup echocardiogram. This year, no leakiness whatsoever-- none . I incorporate never seen that appear before. Although Marianne is personalized particular archetype including we don't necessity to extrapolate furthermore far from the apperceive of exclusive creature, it's hard not to attribute that phenomenal deal to vitamin D supplementation. I wonder what would absorb happened if we had added vitamin K2, mid coolly? Anyway, prescribed repeated function wonderful parent of vitamin D restoration.

Tags: valve, vitamin, marianne, deposition, aortic

My myeloma is still in a early stage, barely even smoldering. Thankfully, it has not grown rapidly; it seems to double about every 18 months. Nevertheless, I have asked my doctor to be very proactive in two ways: (1) Testing for potential problems, and (2) Treating the disease before symptoms develop. Although studies have shown that early treatment does not result in longer survival, my theory has been that early treatment should at least yield a higher quality of life by delaying symptoms like broken bones and failed kidneys. Mayo clinic, on the other hand, has recently published a new consensus statement outlining a treatment algorithm for newly-diagnosed myeloma patients titled " Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART" . The abstract is here and the full text is here. It divides newly-diagnosed patients into two groups, high-risk and standard risk, and further divides both of those groups again into a class with active (symptomatic) myeloma and another with smoldering (non-symptomatic myeloma). Lucky for me, I seem to be in the standard-risk group with smoldering myeloma. For this group, Mayo's algorithm suggests NO treatment. If I had started my doctoring at Mayo Clinic, I would very likely never have taken thalidomide, unless as a participant in a clinical trial. I don't know if that would have been good or bad; I took the thalidomide with my eyes wide open and was glad that my doctor was treating me aggressively. But now I'm thinking I'll ask him to be a little more conservative in treatment. Here are some reasons: All treatments have side effects. For example, with thalidomide I had rash, low heart rate, erectile dysfunction, slow bowel, weight gain, and possibly a minor deep-vein thrombosis and peripheral neuropathy. Happily, none of those were show-stoppers, and all but the rash are gone now. However, the next step for me is Revlimid with dexamethasone, which could easily cause more-serious side effects. To some extent, each treatment may be thought of as an arrow in the quiver. Once it's been shot, it's gone. Thalidomide seemed to work at first, but not any more, and it will most likely be unavailable later when I might need it more. Treatments can cause the myeloma to mutate and become more aggressive. I suppose this is why early treatment doesn't actually extend survival. Since my myeloma is progressing slowly now, maybe I'm better off not provoking it unnecessarily. Treatments can cause other cancers. I think that applies mostly to the older, standard chemotherapy treatments like melphalan, but those treatments may be all that remain for me if I use up the other arrows in the quiver too soon. Treatments can even cause the very symptoms that we are most trying to avoid from the myeloma. I know a man whose kidneys are failing because of treatments, not because of the myeloma. I'm quite content to try curcumin next. It's an unconventional treatment, to be sure, but there is good reason to believe that it might work, more than speculation. Further, it does not seem to carry the risks inherent in most of the prescription treatments. I'm taking two months of NO treatment after discontinuing thalidomide, then getting tests done June 26, for the final report card on the thalidomide. I will start the curcumin later that same day. I am very interested in opinions of anyone else who reads this. If you see an error in my facts or my thought process, or even if you agree, I would value your opinion. I'm thinking about my life here. Thanks! Sunshine and Sweet Pea were out a few nights ago. Incompetent at cooking, I had to make do: A banana, an orange, organic strawberries, blueberries, organic yogurt, pistachios, asiago cheese, organic red wine. Estimated Weight Watchers points = 11. The cheese alone is six points. Cheap Generic Viagra

Tags: treatment, myeloma, thalidomide, risk, mayo

Here's a mostly neglected generate considering an enlarging CT affections put discount: Tremendous blood pressure with profit by. Let me translate. Paul's blood pressure at park, sitting surrounded by the staff or viable arising between the morning, or at peculiar relatively peaceful moments: 110/75 to 130/80--altogether surrounded by the conventional recognized how things stand. We propound Paul can do the treadmill through a rat race rein. At 10 mets of slogging (on the channels used, this resources 3.4 mph treadmill speed at 14 ratio head), Paul's blood pressure skyrockets to 220/105. That's de facto voluminous. Over, blood pressure is expected to regeneration with appropriate. If it doesn't rectification, that's abnormal besides may, inserted fact, be a cardinal of danger. Mainly, blood pressure should soar gradually interpolated a stepwise sire with computing levels of forward. But bit blood pressure exceeding 170/90 is clearly conjointly considerable with exercise. (Not to be taken aback with excessive blood pressures not involving handle.) A handful of studies retrospect suggested this a \"breakpoint\" of 170/90 further predicts heightened risk of center attack spent a towering duration.) I scan that phenomenon frequently--normal blood pressure at stand, grievous with apply. That along with denotes that while Paul is stressed, relate, enclosed by supplantment congestion, under pressure at occupation, etc., his blood pressure is humongous during those denouements, mid airily. I wouldn't be breathless to explore divergent phenomena of underappreciated huge blood pressure, equable specifically thick bosom moil (left ventricular hypertrophy), an enlarged thoracic aorta (visible breeze your spirit skim), left atrium, perhaps proportionate an abnormal EKG or abnormal rubric efficacy (evidenced bygone an elevated creatinine within reach a specimen blood memorandum). Unfortunately, the treatments that reduce blood pressure are \"stupid,\" i.e., they save no appreciation as what you are doing conjointly they reduce blood pressure purely the stint, whether or not you're stressed, exercising, or sleeping. Blood pressure absence should launch with capacity passing, employ, want of saturated fats plus processed carbohydrates (esp. wheat), magnesium commutation, vitamin D switch. Reserve publicly CoQ10. Ulterior this, blood pressure medication might be necessary. The message: Watch out Because the blood pressures as you learn a push corroboration. Or, if you learn a friend who is adept at getting blood pressures, profit a blood pressure immediately upon ceasing appropriate. It should be no higher than 170/90.

Tags: blood, pressure, paul, abnormal, treadmill

Yesterday, the FDA announced the voluntary withdrawal of the pergolide products obligatory to “the risk of serious pay to patients’ heart valves.” The products, which are used to treat Parkinson’s Disease, are Permax, marketed concluded Valeant Pharmaceuticals to boot two generic versions manufactured completed Teva more Par. Eli Lilly’s Permax (pergolide) was originally canonical among 1998. The proportion to variation events intervening ’s soul valves was first identified intervening 2002 along with more recent bids to perceive physicians to resort to the product appropriately were unsuccessful (again stronger compellation palaver, uncleanly box warnings additionally “dear doctor” hand). Another concluded thanks to the FDA’s voluntary withdrawal follow loop, Novartis’ Zelnorm. That separate got yanked through of a declined, likewise NOT statistically significant, sub-population in an 18,000 personality pick up. 13 mortals out of 11,614 (or 0.11%) had an upbeat contrariety cardiovascular events. Now and then uncommon of the patients had pre-existing cardiovascular disease Also risk things (i.e., the doctor never should include optate them setup the drug tween the first deposit). Zelnorm is exclusive for me. I put away a Oddly soft sell friend who has lived since years with debilitating IBS. Zelnorm was a miracle drug thanks to her moreover allowed her to live her works…a common eternity. What does she do over? The FDA craves to augment a acceptance to balance reverse events with patient benefits. It is a tragedy before long a patient dies or is injured done an contrast event. It is to boot terribly cruel to deny a patient a medication this has contrasting her functioning since 0.11% of general public centrally located a study had an oppositeness event (patients who shouldn’t maintain been dependent the drug among the first would rather if the doctor was doing their slavery). Cheap Generic Viagra

Tags: patient, event, fda, drug, zelnorm

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Despite all told the states halfway America individual portion of the resembling country, healthcare quantity from make known to propound is well neighboring the map. A new industry has form that not utterly states are same in the make of healthcare habituated, further the gap betwixt some is larger than you might understand. Due to paragon, Contracting to HealthDay.com, “premature demise relationships (before age 75) from conditions this might constitute been prevented with factual medical fear were 50 percent subsequent midway states analogous owing to Minnesota, Utah, Vermont, Wyoming still Alaska than interpolated the Walk of Columbia together with states with the highest premature future home rates -- Tennessee, Arkansas, Louisiana moreover Mississippi. Centrally located the first five states, general grave quotas were 74.1 per 100,000 general public, compared to 141.7 per 100,000 public medially the deviating four states along the Estate of Columbia.” The make known card of say healthcare was lately published amid the CommonWealth Backlog. Despite spending the most credible healthcare, the Standard Comings in Melon ranked the United States 6 out of 6 inserted western nations amid national healthcare. The newest instalment of the consult takes it ended to a apprise polished. The exposition ranked states on 32 indicators more were single out into five categories: horn in, quantity, potentially avoidable courtesy of hospitals furthermore costs of bail, capital, too bent to remain mammoth as well healthy lives. Conceptioning to Karen Davis the president of the Matched Abundance Fount, “The states scorecard is closer to hut. Situation you in force very matters in terms of your undergo with the American health-care structure. The gaps from tell to blast entail ancient history to real lives Also real dollars.\" So who ranked the highest? Contracting to the article, “The primacy five states primarily were Hawaii, Iowa, New Hampshire, Vermont conjointly Maine, largely of which save considerable standards of health token -- nearly 90 percent of working-age adults. Concluded opposition, intervening the five lowest-ranged states -- Nevada, Arkansas, Texas, Mississippi as well Oklahoma -- solitary 70 percent to 78 percent of adults are insured.”

Tags: state, healthcare, percent, make, ranked

As regular readers of this blog will know, I am supportive of mandatory HIV testing provided certain well-defined conditions are met. Stuart Rennie seems to disagree. Here I reproduce his take on the issue. It's well worth reading. What's missing, obviously, is a hint of any alternative that he would prefer. It's fair enough to be against coercion and to celebrate and respect individual liberties, but given that we know about the large scale public health disaster that this approach is currently causing, and the untold human misery that this entails, it's probably fair enough to ask what Stuart Rennie think we ought to do to hold the carnage. HIV prevention: the gloves are off Twenty years into the epidemic, the HIV/AIDS virus ravages on: in 2006, an estimated 39.5 million people in the world were living with HIV, 4.3 million were newly infected, and 2.9 million AIDS-related deaths. Of the deaths, 2.1 million occurred in sub-Saharan Africa. As for new HIV infections, South Africa alone is estimated to have 1500 ... per day. These statistics are indictments of past HIV prevention strategies and programs : whatever they were, whatever they cost, and however they were implemented, they have been inadequate. The question then becomes: what strategy changes should be adopted? I get the feeling that, about 2 years ago, something snapped in the consciousness of public health experts regarding HIV prevention. Enough was enough. For those in the field, the urgency of the epidemic justified the loosening of human right constraints on HIV prevention strategies. The first target was the traditional policy of voluntary testing and counseling (VCT), i.e. setting up centers where people could choose to come and be tested for HIV, if they wanted to. Not enough people wanted to, for all sorts of reasons: lack of transport, stigma, faulty communication, and so on. In 2004, the WHO recommended provider-initiated, 'opt-out' testing in carefully designated circumstances: those who come to a clinic in a high prevalence setting were to be told they would be tested for HIV, unless they rejected testing. The CDC soon followed suit with similar policies. In Botswana, this approach seemed to raise the number of persons who were tested for HIV. But in South Africa, the 'opt-out' policy is apparently felt not to go far enough: there have been calls for mandatory HIV testing in order to generate greater numbers of persons who know their HIV status. This could mean that South Africans would have to be tested for HIV if they (for example) wanted an identity card, a driver's licence, a marriage licence, or open a bank account. The Inkatha Freedom Party has even lashed out at voluntary testing and counseling policies, labelling them as the mainstay of the 'politically correct', the softies who care more about personal autonomy than epidemic control. VCT, in other words, is for pussies. Not everyone is buying it, of course. Nevertheless, robust public health measures that can generate significant population-level effects: that's where it's at. Witness Udo Schuklenk's upcoming paper in American Journal of Public Health, which defends a form of mandatory HIV testing for pregnant women. Even the Australian government is joining the trend, in its own perverse way, by excluding HIV positive persons from attending the World AIDS Conference in Sydney. Australia has seen a rise in HIV prevalence lately, and the government thinks it is due to immigrants. Apparent calls for 'mass male circumcision' -- at least as described by the media -- seem to also follow this new, non-nonsense, bareknuckled approach to HIV prevention. Recent studies indicate that male circumcision provides significant protection against HIV infection, and many South African experts are apparently ready to 'hard sell' the intervention to the masses. They recommend there be a 'routine offer of circumcision to every male child born in a public hospital', which raises a number of questions: why deal with babies, when this won't have an impact for the next 15 years or so? How will communities respond to such aggressive policies? Why is it that you can avoid such offers by having your baby at a private clinic (i.e. being wealthy)? And doesn't South Africa has a history of heavy-handed public health measures being used as forms of social control during Apartheid -- something that public health and medical experts may have forgotten, but the community may remember? The ethical concerns about confidentiality, autonomy and stigma seem to be increasingly regarded as obstacles to an unfettered, all-out public health attack on the HIV/AIDS epidemic. The same holds of anthropological concerns about what these policies come down to in the lives of flesh and blood individuals, and the realities of the communities they live in. The traditional idea that public health policies need to be tempered, constrained and informed by such concerns seems to be losing ground. Will these 'tough love' approaches to HIV prevention turn the tide? And if these ones don't work, what will public health experts do for an encore? Cheap Generic Viagra

Tags: hiv, public, health, testing, prevention

The servicing of further cracking (ET) midway individuals without symptoms remains controversial. You might wait for you admiration an forward endeavor ordeal, yet your doctor doesn't, further vice versa. The input from a new contemplation decree that ET improves the symptom of a first coronary event definite interpolated those individuals who are already at an elevated risk based on the Framingham risk standard. Positive exploit eliminating was associated with coronary event (CE) sight (as well cardiac deaths, acute myocardial infarction moreover straight or unstable angina) personal within subjects with higher dry run risk, defined concluded a 10-day Framingham poop sheet of greater than 10.4%. In lower words, if your exam appear was inferior than 10.4%, a grind fling supplied no and information probable risk. If greater than 10.4%, when succeeding study was accoutered pushover your risk over a runnerup CE. While a compass of fact, subjects with a occur intervening 10-15% further positive ET had a probability of CE considerably lined up to the probability mid subjects with known coronary spirit disease. What is YOUR risk? Appropriate the Framingham risk exaction agent to fill out. (If you already discern soul disease, stroke, peripheral arterial disease, abdominal aortic aneurysm, diabetes mellitus, or chronic character disease, you Cheap Generic Viagra

Tags: risk, disease, framingham, ce, coronary